Avadel Pharmaceuticals plc
AVDL
Market Cap$907.37M
Close$
$-0.47
105.2% downside
Current Fair Value
105.2% downsideOvervalued by 105.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $907.37 Million |
|---|---|
| Enterprise Value | $857.71 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.51 |
| Beta | 1.4 |
| Outstanding Shares | 96,395,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -18.54 |
|---|---|
| PEG | 19.98 |
| Price to Sales | 9.03 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.21 |
| Enterprise Value to EBIT | -13.4 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Avadel Pharmaceuticals plc
CEO: Gregory Divis